Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts


  Free Subscription


1 Acta Haematol
1 Ann Hematol
4 Blood
1 Bone Marrow Transplant
12 Br J Haematol
1 Cancer
1 Exp Hematol
1 Int J Hematol
3 Leuk Lymphoma
1 Leuk Res
1 N Engl J Med
1 Oncogene
1 PLoS One
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Haematol

  1. SONG X, Peng Y, Wang X, Chen Y, et al
    Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-201
    Acta Haematol. 2018;139:115-127.
    PubMed     Text format     Abstract available

    Ann Hematol

  2. SHIMOMURA Y, Hara M, Katoh D, Hashimoto H, et al
    Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Ann Hematol. 2018 Feb 17. pii: 10.1007/s00277-018-3278.
    PubMed     Text format     Abstract available


  3. GALLIPOLI P, Giotopoulos G, Tzelepis K, Costa ASH, et al
    Glutaminolysis is a metabolic dependency in FLT3(ITD) acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition.
    Blood. 2018 Feb 20. pii: blood-2017-12-820035. doi: 10.1182/blood-2017-12-820035
    PubMed     Text format     Abstract available

  4. ZHENG L, Hu S
    Philadelphia chromosome-positive B-lymphoblastic lymphoma involving the genitourinary system and bone at initial diagnosis and relapse.
    Blood. 2017;130:1483.
    PubMed     Text format    

  5. DONG L, Zheng H, Qu CK
    CCL3 is a key mediator for the leukemogenic effect of Ptpn11 activating mutations in the stem cell microenvironment.
    Blood. 2017 Jul 27. pii: blood-2017-06-791103. doi: 10.1182/blood-2017-06-791103
    PubMed     Text format    

  6. KRAMER I, Stilgenbauer S, Dietrich S, Bottcher S, et al
    Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial.
    Blood. 2017;130:1477-1480.
    PubMed     Text format    

    Bone Marrow Transplant

  7. OCHI K, Fuji S, Takano K, Tajima K, et al
    The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemia.
    Bone Marrow Transplant. 2018 Feb 19. pii: 10.1038/s41409-018-0115.
    PubMed     Text format     Abstract available

    Br J Haematol

  8. COELHO-SILVA JL, Carvalho LE, Oliveira MM, Franca-Neto PL, et al
    Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia.
    Br J Haematol. 2017;176:498-501.
    PubMed     Text format    

  9. TAM CS, Kimber T, Seymour JF
    Ibrutinib monotherapy as effective treatment of central nervous system involvement by chronic lymphocytic leukaemia.
    Br J Haematol. 2017;176:829-831.
    PubMed     Text format    

  10. QUINQUENEL A, Sicre de Fontbrune F, Durot E, Pannetier M, et al
    Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic stem cell transplantation.
    Br J Haematol. 2017;176:997-999.
    PubMed     Text format    

  11. GROVE CS, Bolli N, Manes N, Varela I, et al
    Rapid parallel acquisition of somatic mutations after NPM1 in acute myeloid leukaemia evolution.
    Br J Haematol. 2017;176:825-829.
    PubMed     Text format    

  12. MAHDI AJ, Gosrani D, Chakraborty M, Rees A, et al
    Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes.
    Br J Haematol. 2018;180:603-604.
    PubMed     Text format    

  13. SIVINA M, Werner L, Rassenti L, Ferrajoli A, et al
    Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation.
    Br J Haematol. 2018;180:597-600.
    PubMed     Text format    

  14. ROUTLEDGE DJM, Tower C, Davies E, Scott M, et al
    Successful management of acute myeloid leukaemia in a twin pregnancy - a case report.
    Br J Haematol. 2018;180:605-606.
    PubMed     Text format    

  15. GUPTA A, Das A, Naina HV
    Cholecystitis as the initial presentation of acute myeloid leukaemia.
    Br J Haematol. 2017;176:344.
    PubMed     Text format    

  16. CHETTY T, Masingi NI, Laher Z, Pretorius E, et al
    Acute megakaryoblastic leukaemia: light microscopy and scanning electron microscopy of blast cells.
    Br J Haematol. 2017;176:686.
    PubMed     Text format    

  17. HSU YT, Chen TY
    Relapsing polychondritis as a presenting feature of acute myeloid leukaemia.
    Br J Haematol. 2018;180:472.
    PubMed     Text format    

  18. KAYSER S, Levis MJ
    Advances in targeted therapy for acute myeloid leukaemia.
    Br J Haematol. 2018;180:484-500.
    PubMed     Text format     Abstract available

  19. SUTTON R, Venn NC, Law T, Boer JM, et al
    A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.
    Br J Haematol. 2018;180:550-562.
    PubMed     Text format     Abstract available


  20. HO G, Wun T, Muffly L, Li Q, et al
    Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.
    Cancer. 2018 Feb 16. doi: 10.1002/cncr.31296.
    PubMed     Text format     Abstract available

    Exp Hematol

  21. LI H, Xing C, Zhou B, Ye H, et al
    A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.
    Exp Hematol. 2018 Feb 13. pii: S0301-472X(18)30041.
    PubMed     Text format     Abstract available

    Int J Hematol

  22. NAQVI K, Cortes JE, Luthra R, O'Brien S, et al
    Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutations.
    Int J Hematol. 2018 Feb 20. pii: 10.1007/s12185-018-2422.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  23. CASEY N, Fujiwara H, Azuma T, Murakami Y, et al
    An unusual, CD4 and CD8 dual-positive, CD25 negative, tumor cell phenotype in a patient with adult T-cell leukemia/lymphoma.
    Leuk Lymphoma. 2018 Feb 21:1-3. doi: 10.1080/10428194.2018.1439168.
    PubMed     Text format    

  24. MOLICA S, Levato L, Mirabelli R, Tedeschi A, et al
    Feasibility and safety of therapy with ibrutinib after antiviral control of hepatitis B virus (HBV) reactivation in chronic lymphocytic leukemia patients.
    Leuk Lymphoma. 2018 Feb 21:1-3. doi: 10.1080/10428194.2018.1436175.
    PubMed     Text format    

  25. ROZOVSKI U, Harris DM, Li P, Liu Z, et al
    Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.
    Leuk Lymphoma. 2018 Feb 21:1-6. doi: 10.1080/10428194.2018.1439167.
    PubMed     Text format     Abstract available

    Leuk Res

  26. LI X, Li D, Huang X, Zhou P, et al
    Helios expression in regulatory T cells promotes immunosuppression, angiogenesis and the growth of leukemia cells in pediatric acute lymphoblastic leukemia.
    Leuk Res. 2018;67:60-66.
    PubMed     Text format     Abstract available

    N Engl J Med

  27. EL-JAWAHRI AR, Schaefer PW, El Khoury JB, Martinez-Lage M, et al
    Case 5-2018: A 63-Year-Old Man with Confusion after Stem-Cell Transplantation.
    N Engl J Med. 2018;378:659-669.
    PubMed     Text format    


  28. WANG H, Bei L, Shah CA, Huang W, et al
    The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
    Oncogene. 2018 Feb 20. pii: 10.1038/s41388-018-0131.
    PubMed     Text format     Abstract available

    PLoS One

  29. KLONOFF-COHEN H, Navarro A, Klonoff EA
    Late effects awareness website for pediatric survivors of acute lymphocytic leukemia.
    PLoS One. 2018;13:e0193141.
    PubMed     Text format     Abstract available


  30. ROMEO M, Hutchison T, Malu A, White A, et al
    The human T-cell leukemia virus type-1 p30(II) protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis.
    Virology. 2018;518:103-115.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.